L-cysteine authorized in EU feed 2026: what manufacturers must do

Key data

As of May 8, 2026, EU feed manufacturers have a new nutritional tool available: Commission Implementing Regulation (EU) 2026/1012 formally authorizes L-cysteine and two of its derivatives as additives in feed for all animal species. Authorization is not automatic: incorporating these ingredients requires adapting formulations, technical documentation and labeling to the conditions set by the regulation.

This authorization opens an opportunity for differentiation for manufacturers who want to enrich their formulations with sulfur-containing amino acids, but it also generates compliance obligations that must be managed before marketing products containing them.

What does this regulation establish?

Regulation 2026/1012 establishes the official authorization of three substances from the family of sulfur-containing amino acids for use as additives in feed manufacturing. These substances are:

The authorization allows these substances to be incorporated into feed intended for both farm animals and pets and any other species. The regulation sets technical and labeling requirements that operators must comply with in order to market feed containing these additives.

Before this authorization, these three forms of L-cysteine did not have formal authorization under the European regulatory framework for feed additives. Regulation 2026/1012 opens that door expressly and with defined conditions.

Economic and operational impact

The authorization has a dual effect on the sector:

Business opportunity: Feed manufacturers can now incorporate L-cysteine and its derivatives into their formulations without regulatory risk. This opens the possibility of developing more nutritionally complete products for farm animals, pets and other species, with potential for commercial differentiation.

Adaptation cost: Incorporating these additives is not free in operational terms. Companies must:

• Review and update the technical data sheets of their current or new formulations.
• Adapt the labeling of products that include these substances to the technical requirements of the regulation.
• Update internal documentation (records, safety data sheets, traceability) to reflect the use of the newly authorized additives.
• Verify with additive suppliers that supplies of these three substances comply with the specifications required by the regulation.

For additive distributors, the authorization represents a new product line that they can legally offer to the European market. For livestock farmers, the impact is indirect: the feed they consume may contain these substances, which can improve the nutritional profile of animal feed.

Who does it affect?

• Feed manufacturers: Must adapt formulations, labeling and technical documentation if they wish to incorporate any of the three authorized substances.
• Feed additive producers and distributors: Can legally market L-cysteine, L-cysteine monohydrate hydrochloride and L-cysteine hydrochloride as additives in the European feed market.
• Livestock farmers and livestock operations: Indirectly affected by consuming feed that may incorporate these newly authorized additives.
• Pet feed manufacturers: The authorization covers all animal species, so it also applies to pet food.
• Quality and regulatory managers in sector companies: Must manage documentary adaptation and verify compliance with technical and labeling requirements.

Practical example

A poultry feed manufacturer that wants to launch a new range of feed enriched with sulfur-containing amino acids can now include L-cysteine hydrochloride in its formulation, supported by Regulation 2026/1012.

To do so correctly, this manufacturer must:

1. Verify that the additive supplier supplies L-cysteine hydrochloride with the technical specifications required by the regulation.
2. Update the feed technical data sheet to reflect the inclusion of the newly authorized additive.
3. Adapt the product labeling to comply with the information requirements established in the regulation.
4. Update internal traceability records to document the use of the additive in each batch produced.

If the same manufacturer also produces pet feed, it can apply the same authorization, since the regulation covers all animal species without exception.

What should companies do now?

1. Review the full text of Regulation 2026/1012 on EUR-Lex to identify the exact technical and labeling requirements applicable to each of the three authorized substances.
2. Assess whether the company wants to incorporate any of the three additives (L-cysteine, L-cysteine monohydrate hydrochloride or L-cysteine hydrochloride) into its current or future formulations.
3. Contact additive suppliers to verify availability and conformity of the substances with the regulation's specifications.
4. Update formulations, technical data sheets and labeling of products that will incorporate these additives, complying with the established requirements.
5. Review traceability documentation and internal records to correctly reflect the use of newly authorized additives in each batch.
6. Verify the exact entry into force date in the official text, as it has not been specified in the initial publication, to plan adaptation timelines.